The Hematologic Malignancies Program at
Duke is a leading national center for hematologic cancers,
combining compassionate medical care with state-of-the-art
science to improve outcomes for nearly 1,000 patients with a
cancer of the blood who come to Duke each year.
Duke’s Hematologic Malignancies Program treats patients
battling leukemias, lymphomas, myelomas, myeloadysplasia,
aplasia, and any other blood- and lymphoid-related cancers.
Our Hematologic Malignancy Program takes a holistic approach to address the medical, emotional, and practical needs of our patients.
We alleviate stress and pain through healing touch, massage, aromatherapy, counseling, and patient support programs.
We take particular care to address the needs of our elderly patients, whose physiologic processes require a gentler approach to treatment.
For patients who have treatment-resistant or recurrent cancers, we provide a seamless transition to Duke’s internationally renowned adult bone marrow and stem cell transplant team.
Physicians
Physicians offering this service include:
Locations
This service is available at:
